[BSTEAD] QoQ TTM Result on 31-Dec-2010 [#4]

Stock
[BSTEAD] BOUSTEAD HOLDINGS BHD
Announcement Date
25-Feb-2011
Admission Sponsor
-
Sponsor
-
Financial Year
31-Dec-2010
Quarter
31-Dec-2010 [#4]
Profit Trend
QoQ- 12.85%
YoY- 57.35%
Quarter Report
Latest QR
Upcoming QR
BSTEAD's Result
BSTEAD's Financial Summary
View:
Show?
TTM Result
30/09/11 30/06/11 31/03/11 31/12/10 30/09/10 30/06/10 31/03/10 CAGR
Revenue 7,691,300 7,016,500 6,216,200 6,181,800 5,973,100 5,878,300 5,729,500 21.66%
PBT 837,900 824,500 759,800 726,200 682,200 654,000 550,100 32.34%
Tax -101,400 -107,700 -104,600 -101,300 -112,700 -100,600 -95,300 4.21%
NP 736,500 716,800 655,200 624,900 569,500 553,400 454,800 37.86%
-
NP to SH 627,200 598,200 559,500 537,500 476,300 470,600 371,000 41.86%
-
Tax Rate 12.10% 13.06% 13.77% 13.95% 16.52% 15.38% 17.32% -
Total Cost 6,954,800 6,299,700 5,561,000 5,556,900 5,403,600 5,324,900 5,274,700 20.22%
-
Net Worth 4,352,776 4,343,268 4,222,782 4,230,648 4,091,760 4,054,910 3,950,297 6.67%
Dividend
30/09/11 30/06/11 31/03/11 31/12/10 30/09/10 30/06/10 31/03/10 CAGR
Div 394,883 300,932 394,363 365,380 343,735 282,931 222,053 46.73%
Div Payout % 62.96% 50.31% 70.48% 67.98% 72.17% 60.12% 59.85% -
Equity
30/09/11 30/06/11 31/03/11 31/12/10 30/09/10 30/06/10 31/03/10 CAGR
Net Worth 4,352,776 4,343,268 4,222,782 4,230,648 4,091,760 4,054,910 3,950,297 6.67%
NOSH 940,124 940,101 940,486 940,144 940,634 934,311 925,128 1.07%
Ratio Analysis
30/09/11 30/06/11 31/03/11 31/12/10 30/09/10 30/06/10 31/03/10 CAGR
NP Margin 9.58% 10.22% 10.54% 10.11% 9.53% 9.41% 7.94% -
ROE 14.41% 13.77% 13.25% 12.70% 11.64% 11.61% 9.39% -
Per Share
30/09/11 30/06/11 31/03/11 31/12/10 30/09/10 30/06/10 31/03/10 CAGR
RPS 818.12 746.36 660.96 657.54 635.01 629.16 619.32 20.37%
EPS 66.71 63.63 59.49 57.17 50.64 50.37 40.10 40.35%
DPS 42.00 32.00 42.00 39.00 36.54 30.28 24.00 45.17%
NAPS 4.63 4.62 4.49 4.50 4.35 4.34 4.27 5.53%
Adjusted Per Share Value based on latest NOSH - 940,144
30/09/11 30/06/11 31/03/11 31/12/10 30/09/10 30/06/10 31/03/10 CAGR
RPS 379.44 346.15 306.67 304.97 294.68 290.00 282.66 21.66%
EPS 30.94 29.51 27.60 26.52 23.50 23.22 18.30 41.87%
DPS 19.48 14.85 19.46 18.03 16.96 13.96 10.95 46.76%
NAPS 2.1474 2.1427 2.0833 2.0871 2.0186 2.0004 1.9488 6.67%
Price Multiplier on Financial Quarter End Date
30/09/11 30/06/11 31/03/11 31/12/10 30/09/10 30/06/10 31/03/10 CAGR
Date 30/09/11 30/06/11 31/03/11 30/12/10 30/09/10 30/06/10 31/03/10 -
Price 4.49 5.51 5.22 4.79 4.38 3.52 3.13 -
P/RPS 0.55 0.74 0.79 0.73 0.69 0.56 0.51 5.15%
P/EPS 6.73 8.66 8.77 8.38 8.65 6.99 7.80 -9.36%
EY 14.86 11.55 11.40 11.94 11.56 14.31 12.81 10.39%
DY 9.35 5.81 8.05 8.14 8.34 8.60 7.67 14.10%
P/NAPS 0.97 1.19 1.16 1.06 1.01 0.81 0.73 20.84%
Price Multiplier on Announcement Date
30/09/11 30/06/11 31/03/11 31/12/10 30/09/10 30/06/10 31/03/10 CAGR
Date 21/11/11 18/08/11 27/05/11 25/02/11 29/11/10 23/08/10 31/05/10 -
Price 4.85 4.90 5.10 4.81 4.68 3.88 3.15 -
P/RPS 0.59 0.66 0.77 0.73 0.74 0.62 0.51 10.19%
P/EPS 7.27 7.70 8.57 8.41 9.24 7.70 7.85 -4.98%
EY 13.76 12.99 11.66 11.89 10.82 12.98 12.73 5.31%
DY 8.66 6.53 8.24 8.11 7.81 7.80 7.62 8.89%
P/NAPS 1.05 1.06 1.14 1.07 1.08 0.89 0.74 26.24%

PBT = Profit before Tax, NP = Net Profit, NP to SH = Net Profit Attributable to Shareholder, Div = Dividend, NP Margin = Net Profit Margin, ROE = Return on Equity, NOSH = Number of Shares, RPS = Revenue per Share, EPS = Earning Per Share, DPS = Dividend Per Share, NAPS = Net Asset Per Share, EOQ = End of Quarter, ANN = Announcement, P/RPS = Price/Revenue per Share, P/EPS = Price/Earning per Share, P/NAPS = Price/Net Asset per Share, EY = Earning Yield, DY = Dividend Yield.

NOSH is estimated based on the NP to SH and EPS. Div is an estimated figure based on the DPS and NOSH. Net Worth is an estimated figure based on the NAPS and NOSH.

Div Payout %, NP Margin, ROE, DY, QoQ ⃤ & YoY ⃤ figures in Percentage; RPS, EPS & DPS's figures in Cent; and NAPS's figures in Dollar.

All figures in '000 unless specified.

Discussions
Be the first to like this. Showing 0 of 0 comments
Post a Comment